×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AORT – artivion, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AORT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
07:31 pm
aort
How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates [Yahoo! Finance]
Medium
Report
How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates [Yahoo! Finance]
4/13
05:58 pm
aort
1 Stock Under $50 to Own for Decades and 2 We Avoid [Yahoo! Finance]
Low
Report
1 Stock Under $50 to Own for Decades and 2 We Avoid [Yahoo! Finance]
4/10
08:43 am
aort
Artivion (AORT) was upgraded by LADENBURG THALM/SH SH from "neutral" to "buy". They now have a $42.00 price target on the stock.
Low
Report
Artivion (AORT) was upgraded by LADENBURG THALM/SH SH from "neutral" to "buy". They now have a $42.00 price target on the stock.
4/8
08:13 pm
aort
Artivion Secures FDA Approval for NEXUS Aortic Arch System [Yahoo! Finance]
Low
Report
Artivion Secures FDA Approval for NEXUS Aortic Arch System [Yahoo! Finance]
4/7
04:58 pm
aort
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know [Yahoo! Finance]
Low
Report
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know [Yahoo! Finance]
4/7
01:45 pm
aort
Artivion (AORT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $58.00 price target on the stock.
Low
Report
Artivion (AORT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $58.00 price target on the stock.
4/7
07:00 am
aort
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
Low
Report
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
4/6
07:48 pm
aort
Why Artivion (AORT) Stock Is Down Today [Yahoo! Finance]
Low
Report
Why Artivion (AORT) Stock Is Down Today [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
04:21 pm
aort
Form ARS ARTIVION, INC. For: Dec 31
Low
Report
Form ARS ARTIVION, INC. For: Dec 31
4/1
04:19 pm
aort
Form DEF 14A ARTIVION, INC. For: May 12
Low
Report
Form DEF 14A ARTIVION, INC. For: May 12
3/26
03:46 pm
aort
Form SCHEDULE 13G/A ARTIVION, INC. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A ARTIVION, INC. Filed by: VANGUARD GROUP INC
3/4
06:55 pm
aort
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Horton Amy
Low
Report
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Horton Amy
3/4
06:53 pm
aort
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Holloway Jean F
Low
Report
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Holloway Jean F
3/4
06:51 pm
aort
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Stanton Marshall S.
Low
Report
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Stanton Marshall S.
3/4
06:49 pm
aort
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Davis John E
Low
Report
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Davis John E
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: